In our approach, it is based on being unable to reject H 0 at modest significance levels.
← all excerpts
Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit.
1
—
—
In our approach, it is based on being unable to reject H 0 at modest significance levels.